Quantcast

Latest NewCardio Inc. Stories

2011-02-15 07:00:00

SANTA CLARA, Calif., Feb. 15, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the American College of Cardiology (ACC) to present the results of a key study showing that NewCardio's urgent care solution, my3KG(TM), had substantially greater accuracy than expert cardiologists' interpretation of standard 12-lead ECG (12L ECG) in diagnosing Acute Myocardial Infarction (AMI)...

2011-02-08 07:00:00

SANTA CLARA, Calif., Feb. 8, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited to present the results of a key QTinno® performance study at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics (ASCPT), to be held in Dallas, March 3-5, 2011. The study, entitled "Intelligent Automated ECG Extraction from Continuous...

2010-12-10 07:00:00

SANTA CLARA, Calif., Dec. 10, 2010 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, today presented the results from a blinded drug safety study conducted by the Cardiac Safety Research Consortium (CSRC) to evaluate the performance of QTinno(TM) on its "testing" ECG dataset. The CSRC blinded "testing" dataset, comprised of 11,672 electrocardiograms (ECGs) from the moxifloxacin and placebo arms of a recent parallel-group Thorough...

2010-12-02 07:00:00

SANTA CLARA, Calif., Dec. 2, 2010 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that Dr. Dorin Panescu, Chief Technical Officer and Vice President Research and Development, has been named an IEEE Fellow, effective January 1, 2011. The IEEE Grade of Fellow is conferred by the IEEE Board of Directors upon a person with an outstanding record of accomplishments in any of the IEEE fields of interest. The total...

2010-11-15 15:01:00

SANTA CLARA, Calif., Nov. 15, 2010 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced financial results for the third quarter and nine months ended September 30, 2010. More details on the financial results are available in the SEC Form 10-Q, filed today with the Securities and Exchange Commission. "We continue to make progress in the commercialization of our initial solution, QTinno(TM), and in securing the...

2010-11-09 07:00:00

SANTA CLARA, Calif., Nov. 9, 2010 /PRNewswire-FirstCall/ -- NewCardio, Inc. (OTC Bulletin Board: NWCI), a cardiovascular diagnostic solutions developer, announced today that Dr. Samuel George, NewCardio's Senior Medical Advisor, will present the results of QTinno performance on a blinded "testing" dataset, conducted independently by the Cardiac Safety Research Consortium (CSRC), at the CSRC's Annual Meeting, to be held on December 9, 2010, at the headquarters of the Food and Drug...

2010-10-29 07:00:00

SANTA CLARA, Calif., Oct. 29 /PRNewswire-FirstCall/ -- NewCardio, Inc. (OTC Bulletin Board: NWCI), a cardiovascular diagnostic solutions developer, announced today that the Company expects to file its Form 10-Q for the third quarter ended September 30, 2010 on November 15, 2010 and management will conduct a conference call to provide a corporate update and discuss progress as follows: What: NewCardio Corporate Update Conference Call When: 1:30 p.m. PT/ 4:30 p.m. ET, Monday, November...

2010-10-12 07:00:00

SANTA CLARA, Calif., Oct. 12 /PRNewswire-FirstCall/ -- NewCardio, Inc. (OTC Bulletin Board: NWCI), a cardiovascular diagnostic solutions developer, announced today that Dr. Ihor Gussak, MD, PhD, FACC, NewCardio's Vice President and Chief Medical Officer, will join a distinguished roster of speakers, moderators and panelists at the Cambridge Healthtech Institute (CHI) inaugural conference entitled "Mitigating Safety Risks in Early Clinical Development." The conference, which NewCardio will...

2010-09-28 07:00:00

SANTA CLARA, Calif., Sept. 28 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that Dr. Ihor Gussak, NewCardio's Vice President and Chief Medical Officer, has been invited by the FDA, Drug Information Association (DIA), and the Cardiac Safety Research Consortium (CSRC) to present at the Diabetic Drug Safety Conference meeting entitled "Development of Type 2 Diabetes Mellitus Drugs: State-of-the-Art Cardiovascular...

2010-09-16 07:00:00

SANTA CLARA, Calif., Sept. 16 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno(TM) solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related